Rel-O-2050

CAT: 0804-HY-110020Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-110020Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Rel-O-2050 (Compound O-2050) is a neutral cannabinoid CB1 receptor antagonist. rel-O-2050 also decreases food intake in mice[1].
CAS Number
[851320-29-1]
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rel-o-2050.html
Solubility
10 mM in DMSO
Smiles
CS(=O)(NCCCC#CCC1=CC(O)=C([C@@]2([H])[C@](CC=C(C)C2)([H])C(C)(C)O3)C3=C1)=O
Molecular Formula
C23H31NO4S
Molecular Weight
417.56
References & Citations
[1]Wiley JL, et al. Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB (1) receptor antagonist. Eur J Pharmacol. 2011 Jan 25;651 (1-3) :96-105.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1

Related Products

CatalogName
HY-133533O-2050
HY-I1031-01Rel-Bedaquiline
HY-15322A(rel) -PRT062607
HY-18295A-01Rel-Erteberel
HY-124874(rel) -Asperparaline A
HY-114163ARel-ML123
HY-106874BRel-Delequamine
HY-122359A-01Rel-Levormeloxifene
HY-112163A-01Rel-Zotatifin
HY-117283Rel-Aprikalim

Alternative Products

CatalogName
MF-0092469-01rel-O-2050
B5156-10O-2050
O003002O-2050-D3,13C
063118BT-508-WT-2050 AB Labels
063120BT-508-YL-2050 AB Labels
030817C-rel (REL, Proto-oncogene c-Rel)
225514-01REL (Proto-Oncogene c-Rel, REL) discontinued
TS411878P5c Rel (REL) CytoSection
RQ7814REL Antibody / c-Rel
574561-01REL

Popular Products